| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1033517783 |
| P356 | DOI | 10.1186/1471-2172-9-6 |
| P932 | PMC publication ID | 2275217 |
| P698 | PubMed publication ID | 18312620 |
| P5875 | ResearchGate publication ID | 5538911 |
| P50 | author | Katri Haimila | Q75231243 |
| Katri Kaukinen | Q102075472 | ||
| Ilma R Korponay-Szabo | Q125194834 | ||
| Satumarja M Stenman | Q125195169 | ||
| Markku Mäki | Q16989186 | ||
| Jukka Partanen | Q42707962 | ||
| Olli Lohi | Q56480958 | ||
| P2093 | author name string | Katri Lindfors | |
| Päivi Saavalainen | |||
| Herbert Wieser | |||
| P2860 | cites work | Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. | Q64966964 |
| In vitro pathogenetic studies of coeliac disease. Effects of protein digests on coeliac intestinal biopsy specimens maintained in culture for 48 hours | Q66894070 | ||
| Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition | Q68541043 | ||
| Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients | Q71035831 | ||
| In vitro toxicity of gluten peptides in coeliac disease assessed by organ culture | Q71541489 | ||
| Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease | Q71693082 | ||
| Peptic-tryptic digests of gliadin: contaminating trypsin but not pepsin interferes with gastrointestinal protein binding characteristics | Q71782199 | ||
| Endomysial antibody production is not related to histological damage after in vitro gluten challenge | Q73403534 | ||
| Forty-eight hours of biopsy culture improve the sensitivity of the in vitro gliadin challenge in the diagnosis of celiac disease | Q74542282 | ||
| In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease | Q77319028 | ||
| Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease | Q77620657 | ||
| Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis | Q77635191 | ||
| Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture | Q24669749 | ||
| Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits | Q24679813 | ||
| Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. | Q30657383 | ||
| Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease | Q34213073 | ||
| Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study. | Q34435922 | ||
| Autoantibody targeting of brain and intestinal transglutaminase in gluten ataxia | Q34494273 | ||
| In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. | Q34649501 | ||
| HLA-DQ2-negative celiac disease in Finland and Spain. | Q34746827 | ||
| Organ culture of mucosal biopsies of human small intestine | Q35572074 | ||
| Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer | Q36355809 | ||
| Recombinant human interleukin 10 suppresses gliadin dependent T cell activation in ex vivo cultured coeliac intestinal mucosa. | Q40481891 | ||
| Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues | Q43003801 | ||
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 6 | |
| P577 | publication date | 2008-02-29 | |
| P1433 | published in | BMC Immunology | Q2877163 |
| P1476 | title | Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits | |
| P478 | volume | 9 |
| Q57937529 | Are Transglutaminase 2 Inhibitors Able to Reduce Gliadin-Induced Toxicity Related to Celiac Disease? A Proof-of-Concept Study |
| Q38364232 | Beyond the Intestinal Celiac Mucosa: Diagnostic Role of Anti-TG2 Deposits, a Systematic Review |
| Q98177686 | Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder |
| Q34022801 | Degradation of coeliac disease-inducing rye secalin by germinating cereal enzymes: diminishing toxic effects in intestinal epithelial cells. |
| Q38144156 | Diagnostic dilemmas in celiac disease |
| Q46057460 | Enzymatic detoxification of gluten by germinating wheat proteases: implications for new treatment of celiac disease. |
| Q39277546 | Gluten-related disorders: certainties, questions and doubts |
| Q45220418 | Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. |
| Q87770073 | Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in coeliac disease |
| Q37224943 | Isolation and culture of fibroblasts from endoscopic duodenal biopsies of celiac patients |
| Q36476484 | Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease |
| Q38720803 | Novel diagnostic techniques for celiac disease |
| Q39696137 | Nuclear fluorescence serum reactivity on monkey oesophagus: a new antibody for the follow-up of coeliac disease? |
| Q37772795 | Proteomic analyses lead to a better understanding of celiac disease: focus on epitope recognition and autoantibodies. |
| Q35685749 | Responsive population dynamics and wide seeding into the duodenal lamina propria of transglutaminase-2-specific plasma cells in celiac disease |
| Q47270920 | Usefulness of the organ culture system when villous height/crypt depth ratio, intraepithelial lymphocyte count, or serum antibody tests are not diagnostic for celiac disease |
Search more.